Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE- A Phase III Study to Evaluate Long-Acting Antiretroviral Therapy in Non-Adherent HIV-Infected Individuals
Long-Acting ART in Non-Adherent Participants
Enrolling:Male and Female Patients
Minimum Age:18 years old
IRB Number:AAAR9995
U.S. Government ID:NCT03635788
Contact: Anyelina Cantos: 212-305-7897 /
Additional Study Information:

We are doing a research study to find out if Long-Acting Injectable anti-HIV medications will be more successful than standard pills for people who have a hard time taking their HIV pills. If you are over the age of 18 years old, have been prescribed HIV medications but have had difficulty getting undetectable viral load (when the levels of virus in the blood stream are so low that they can't be measured), you may be eligible. You may receive up to $1100 for the first 5 months of participation. Contact us to find out more about this study.

Do You Qualify?
Are you 18 years of age or older?YesNo
Are you HIV+ (HIV positive)?YesNo
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Anyelina Cantos
Phone: 212-305-7897